Jane Street Group, LLC Adaptimmune Therapeutics PLC Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 16, 2021	BUY	$3.44 - $6.37 $25,456 - $47,138	7,400 Added 45.68%	23,600 $122,000
Q1 2021 May 18, 2021	SELL	$4.9 - $6.83 $244,510 - $340,817	-49,900 Reduced 75.49%	16,200 $86,000
Q4 2020 Feb 17, 2021	BUY	$4.0 - $9.2 $264,400 - $608,120	66,100 New	66,100 $356,000
Q3 2020 Nov 17, 2020	SELL	$7.66 - $10.78 $220,608 - $310,464	-28,800 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$2.58 - $12.1 $74,304 - $348,480	28,800 New	28,800 $288,000

150M

60.8K

5.8K

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.